Breast cancer markers

被引：36

作者：

Giancotti, Vincenzo ^{[1
]}

机构：

[1] Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34127 Trieste, Italy

来源：

CANCER LETTERS | 2006年 / 243卷 / 02期

关键词：

breast cancer; markers; kinases;

D O I：

10.1016/j.canlet.2006.01.035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This review illustrates the relationships linking the ER and the ErbB family of receptor tyrosine kinases and their kinase pathways in breast cancer. The central role of the ER in activating tumour growth linked gene transcription as well as the cooperating nuclear co-factors very likely implicated in breast cancer tumourigenesis is discussed. The action of ErbB family members has been located upstream of the kinase pathways that begin at plasma membrane and end at the nucleus after complex interconnections with many factors, such as AP-1. The important role of MAPKs and PKB/Akt in cell survival and tumour proliferation is highlighted. Also other factors are discussed such as Fra-1 (a member of the AP-1 complex), E-cadherin (a tumour suppressor), and BRCA1 (another factor involved in tumour growth inhibition). Lactoferrin protein (characteristic of healthy tissues) and resistance proteins have also been briefly discussed. (c) 2006 Elsevier Ireland Ltd. All rights reserved.

引用

页码：145 / 159

页数：15

共 104 条

[1] High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses [J].

Abd El-Rehim, DM ;

Ball, G ;

Pinder, SE ;

Rakha, E ;

Paish, C ;

Robertson, JFR ;

Macmillan, D ;

Blamey, RW ;

Ellis, IO .

INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (03) :340-350

[2] Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3β [J].

Al-Khouri, AM ;

Ma, YL ;

Togo, SH ;

Williams, S ;

Mustelin, T .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) :35195-35202

[3] Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver [J].

Albermann, N ;

Schmitz-Winnenthal, FH ;

Z'graggen, K ;

Volk, C ;

Hoffmann, MM ;

Haefeli, WE ;

Weiss, J .

BIOCHEMICAL PHARMACOLOGY, 2005, 70 (06) :949-958

[4]

Arpino G, 2004, BREAST CANCER RES TR, V88, pS21

[5]

Arpino G, 2004, BREAST CANCER RES TR, V88, pS15

[6] Nuclear factor-κB and liver carcinogenesis [J].

Arsura, M ;

Cavin, LG .

CANCER LETTERS, 2005, 229 (02) :157-169

[7]

Arteaga CL, 2004, BREAST CANCER RES TR, V88, pS15

[8] Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma [J].

Baldassarre, G ;

Battista, S ;

Belletti, B ;

Thakur, S ;

Pentimalli, F ;

Trapasso, F ;

Fedele, M ;

Pierantoni, G ;

Croce, CM ;

Fusco, A .

MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (07) :2225-2238

[9] Increase in AP-1 activity is a general event in thyroid cell transformation in vitro and in vivo [J].

Battista, S ;

de Nigris, F ;

Fedele, M ;

Chiappetta, G ;

Scala, S ;

Vallone, D ;

Pierantoni, GM ;

Megar, T ;

Santoro, M ;

Viglietto, G ;

Verde, P ;

Fusco, A .

ONCOGENE, 1998, 17 (03) :377-385

[10] FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells [J].

Belguise, K ;

Kersual, N ;

Galtier, F ;

Chalbos, D .

ONCOGENE, 2005, 24 (08) :1434-1444

← 1 2 3 4 5 6 7 8 9 10 →